Article
Practical Synthesis and Evaluation of the Biological Activities of 1α,25-dihydroxyvitamin D3 Antagonists, 1α,25-dihydroxyvitamin D3-26,23-lactams. Designed on the Basis of the Helix 12-Folding Inhibition Hypothesis
University of Tokyo.
Teijin Institute for Bio-medical Research.
Astellas Pharma Inc..
To whom correspondence should be addressed. Tel: +81-42-388-7295. Fax: +81-42-388-7295. E-mail: knaga@cc.tuat.ac.jp.
Tokyo University of Agriculture and Technology.
Abstract

A practical synthetic route to novel vitamin D antagonists of DLAM (1α,25-dihydroxyvitamin D3-26,23-lactam) was developed from vitamin D2 via the 1,3-dipolar cycloaddition reaction as a key step. Six DLAM derivatives (24 compounds) with a variety of nitrogen substituents and stereochemistries at C23 and C25 were synthesized. Among these new derivatives, (23S,25S)-DLAM isomers bound effectively to VDRs and showed antagonistic activity in the HL-60 cell differentiation inhibition assay. The importance of the substituent on the nitrogen of DLAMs for antagonistic activity was also suggested by computational docking studies.
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
Accession Codes
History
- Published In Issue April 20, 2006
- Received July 29, 2005
Cart



